BioSpace's List of January 2019 Life Science IPOs

January 2019 IPO Filings and Pricings, Updated 1/15/19

Know of an IPO since Jan. 1, 2019 that we missed? Email us at news@biospace.com 

Related: Check out BioSpace's October listNovember list, and December list

Date Company Name Amount (USD) Company HQ Research Focus
1/15/19 INmune Bio $20M Priced La Jolla, CA Modulate innate immune system to respond to cancer
1/14/19 Brainsway $30M Filed Jerusalem, Israel Deep TMS technology for the treatment of MDD and OCD
1/11/19 Cirius Therapeutics $86M Filed San Diego, CA Innovative therapies for the treatment of liver and metabolic diseases
1/11/19 Kaleido Biosciences $100M Filed Lexington, MA Modulate the metabolic output and profile of the body's microbiome
1/7/19 Alector $150M Filed San Francisco, CA Develop therapies that empower the immune system to cure neurodegeneration
1/7/19 Anchiano Therapeutics $35M Filed Jerusalem, Israel Genetic therapy for early-stage bladder cancer
1/4/19 Poseida Therapeutics  $115M Priced San Diego, CA CAR-T products to treat hematological malignancies and solid tumors
1/4/19 China SXT Pharmaceuticals $10.2M Priced Taizhou, China Research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces

 

 

 

 

 

Click here to get the latest life sciences news straight to your inbox. Subscribe now to our FREE newsletters

Back to news